Fresenius Medical Care AG & Co. KGaA
www.fmc-ag.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Fresenius Medical Care AG & Co. KGaA
Ozempic Cuts Kidney Risk By 24%
But Novo’s blockbuster lags established drugs in diabetic kidney disease patients, and will probably be regarded as an adjunct.
The FLOW Of Novo Nordisk's Semaglutide Success Rolls Into Kidney Disease
The Danish giant’s GLP-1 agonist blockbuster is effective against diabetes, obesity and cardiovascular disease. Now kidney disease can be added to the list after a Phase III trial was halted for efficacy.
After US Woes, Akebia Celebrates EU Nod For Vafseo
The US biotech is in the throes of an appeal to the FDA against the rejection of its HIF-PH inhibitor but regulators in the EU have looked more kindly on vadadustat, which will be sold as Vafseo.
Minute Insight: FDA Approves Fresenius Medical’s Lightweight Peritoneal Dialysis System
The VersiPD peritoneal system is the lightest, smallest and quietest dialysis system in the US, according to the company.
Company Information
- Industry
- Laboratory Testing Services
- Medical Devices
- Pharmaceuticals
- Services
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice